- Tytuł:
- P.17.8 The co-formulation of pharmacological chaperone AT2220 with recombinant human acid alpha-glucosidase improves enzyme uptake and glycogen reduction in a mouse model of Pompe disease
- Autorzy:
- Źródło:
-
In
Neuromuscular Disorders October 2013 23(9-10):828-829
Czasopismo naukowe